Name: Bioworkshops sell "Palivizumab"
Brand: Bioworkshops
Availability: InStock

287

4.4(67)

Category

Subcategory & Sub-subcategory

Trade Type

Sell

Product Name

Palivizumab

Manufacturer(s)

Specifications

Regulatory Status: Developed from a cell line with DMF filing in place, ensuring global regulatory readiness and streamlined submission for this RSV F-protein inhibitor mAb (originator: AbbVie, first approved 1998-06-19, United States).
Purity: Demonstrates a high degree of analytical comparability to the reference product, supporting regulatory and clinical acceptance as a biosimilar.
Expression System: Produced from an optimized, high-titer mammalian cell line and process delivering consistently strong productivity for cost-efficient large-scale manufacturing, with broad media adaptability across multiple platforms.

Bioworkshops sell "Palivizumab"

Ratings